Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | uridine | 20 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 39 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 42 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 44 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 51 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 54 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 54 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 58 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 59 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 62 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 63 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 64 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 66 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 66 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 67 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 68 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 68 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 69 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 69 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 71 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 71 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 71 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 71 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 71 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 73 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 73 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 74 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 74 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 75 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 75 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 76 | Counts | 60-64 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 76 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 76 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 77 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 77 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 78 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 78 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 78 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 79 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 80 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 80 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 81 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 81 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 81 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 81 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 81 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 81 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 82 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 82 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 82 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 82 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 83 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 83 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 84 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 84 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 85 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 85 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 85 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 87 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 87 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 87 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 87 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 88 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 88 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 88 | Counts | 60-64 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 88 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 88 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 89 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 89 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 89 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 90 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 90 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 90 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 91 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 91 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 92 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 93 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 93 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 93 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 93 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 94 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 94 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 94 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 94 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 95 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 95 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 95 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 98 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 98 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 99 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 100 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 100 | Counts | 50-54 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 100 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 100 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 100 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 101 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 102 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 102 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 102 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 102 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 103 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 103 | Counts | 60-64 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 104 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 104 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 104 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 105 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 105 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 105 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 106 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 106 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 106 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 107 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 107 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 107 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 108 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 108 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 108 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 109 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 109 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 111 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 111 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 112 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 112 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 113 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 113 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 113 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 114 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 114 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 114 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 116 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 117 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 117 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 117 | Counts | 65-69 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 118 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 118 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 119 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 120 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 120 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 120 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 120 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 120 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 121 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 121 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 121 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 122 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 123 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 123 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 124 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 125 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 125 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 126 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 131 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 132 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 132 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | uridine | 132 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 134 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 134 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 134 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 134 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 134 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 136 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 136 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 136 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 137 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 137 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 138 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 138 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 138 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 140 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 140 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 141 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 143 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 143 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 144 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 145 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 145 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 146 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 147 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 147 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 148 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 149 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 149 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 149 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 150 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 150 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 151 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | uridine | 151 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 151 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 151 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | uridine | 152 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 152 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | uridine | 153 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | uridine | 153 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 153 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 153 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | uridine | 154 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | uridine | 154 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 155 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | uridine | 155 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | uridine | 156 | Counts | 60-64 | Male | Former | - |
Return to search page